These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8943855)
21. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318 [TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Guasch JF; Lensen RP; Bertina RM Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576 [TBL] [Abstract][Full Text] [Related]
23. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. van Boven HH; Vandenbroucke JP; Briët E; Rosendaal FR Blood; 1999 Oct; 94(8):2590-4. PubMed ID: 10515862 [TBL] [Abstract][Full Text] [Related]
24. Molecular basis for protein C hereditary deficiency. Aiach M; Gandrille S Haemostasis; 1996 Oct; 26 Suppl 4():9-19. PubMed ID: 8979107 [TBL] [Abstract][Full Text] [Related]
25. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391 [TBL] [Abstract][Full Text] [Related]
26. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Ehrenforth S; Junker R; Koch HG; Kreuz W; Münchow N; Scharrer I; Nowak-Göttl U Eur J Pediatr; 1999 Dec; 158 Suppl 3():S97-104. PubMed ID: 10650845 [TBL] [Abstract][Full Text] [Related]
27. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445 [TBL] [Abstract][Full Text] [Related]
28. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401 [TBL] [Abstract][Full Text] [Related]
29. Dual genetic abnormality in the coagulation pathway as a cause of familial thrombophilia. Khaira A; Kalra OP; Gupta A; Khaira DD J Assoc Physicians India; 2009 Jul; 57():529-30. PubMed ID: 20329415 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of inherited thrombophilia in young thrombosis patients from the East Bohemian region. Dulícuek P; Malý J; Pesuavová L; Pecka M Blood Coagul Fibrinolysis; 2002 Sep; 13(6):569-73. PubMed ID: 12192310 [TBL] [Abstract][Full Text] [Related]
31. The factor V gene A4070G mutation and the risk of venous thrombosis. Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990 [TBL] [Abstract][Full Text] [Related]
33. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Dahlbäck B Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707 [TBL] [Abstract][Full Text] [Related]
34. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. de Visser MC; Rosendaal FR; Bertina RM Blood; 1999 Feb; 93(4):1271-6. PubMed ID: 9949170 [TBL] [Abstract][Full Text] [Related]
35. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778 [TBL] [Abstract][Full Text] [Related]
36. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Zöller B; Berntsdotter A; García de Frutos P; Dahlbäck B Blood; 1995 Jun; 85(12):3518-23. PubMed ID: 7780138 [TBL] [Abstract][Full Text] [Related]
37. Pregnancy-related thrombosis risk in patients with protein C deficiency and comparison with pregnant women with heterozygous factor V Leiden mutation. Rugeri L; Desage S; Khouatra L; Battie C; Doret-Dion M; Trzeciak C; Dargaud Y Blood Coagul Fibrinolysis; 2020 Jan; 31(1):55-59. PubMed ID: 31833868 [TBL] [Abstract][Full Text] [Related]
38. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Rosendaal FR; Koster T; Vandenbroucke JP; Reitsma PH Blood; 1995 Mar; 85(6):1504-8. PubMed ID: 7888671 [TBL] [Abstract][Full Text] [Related]
39. Hereditary thrombophilia and venous thromboembolism. Murin S; Marelich GP; Arroliga AC; Matthay RA Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1369-73. PubMed ID: 9817680 [TBL] [Abstract][Full Text] [Related]
40. The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome. Guan ZY; Yu CW; Song T; Gao Y Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2742-2750. PubMed ID: 29771426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]